OS Animal Health is featured at the Moody Capital 2026 Disruptive Growth & Life Sciences Conference, spotlighting its OST-HER2 immunotherapy for canine osteosarcoma. The company aims to lead HER2-positive cancer treatment for companion animals. #VeterinaryOncology #Biotech